SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-219995
Filing Date
2019-08-13
Accepted
2019-08-13 16:29:04
Documents
23
Period of Report
2019-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d770430d8k.htm   iXBRL 8-K 39494
2 EX-4.1 d770430dex41.htm EX-4.1 523498
3 EX-99.1 d770430dex991.htm EX-99.1 8578
4 EX-99.2 d770430dex992.htm EX-99.2 9509
8 GRAPHIC g770430dsp63.jpg GRAPHIC 2173
9 GRAPHIC g770430g0812210217643.jpg GRAPHIC 3429
10 GRAPHIC g770430g0812210449418.jpg GRAPHIC 3429
11 GRAPHIC g770430page64.jpg GRAPHIC 2823
12 GRAPHIC g770430page65.gif GRAPHIC 810
13 GRAPHIC g770430page66.jpg GRAPHIC 3054
14 GRAPHIC g770430page67.jpg GRAPHIC 6975
15 GRAPHIC g770430page68.jpg GRAPHIC 3601
  Complete submission text file 0001193125-19-219995.txt   865109

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clvs-20190807.xsd EX-101.SCH 3086
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20190807_lab.xml EX-101.LAB 18137
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20190807_pre.xml EX-101.PRE 11418
16 EXTRACTED XBRL INSTANCE DOCUMENT d770430d8k_htm.xml XML 3188
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 191021038
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1